(Q29994602)

English

Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis

scientific article (publication date: April 2017)

In more languages

Statements

scholarly article

0 references

6 references

13 March 2019

14 March 2019

24 March 2019

20 November 2019

31 August 2020

4 February 2021

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis (English)

0 references

1 reference

20 November 2019

type 2 diabetes

3 references

20 November 2019

31 August 2020

4 February 2021

diabetic nephropathy

2 references

31 August 2020

4 February 2021

author name string

Yong-Chao Qiao

1

0 references

Yin-Ling Chen

2

0 references

Yan-Hong Pan

3

0 references

Wei Ling

4

0 references

Fang Tian

5

0 references

Xiao-Xi Zhang

6

0 references

Hai-Lu Zhao

7

0 references

language of work or name

0 references

publication date

April 2017

0 references

1 April 2017

6 references

13 March 2019

14 March 2019

24 March 2019

20 November 2019

29 May 2020

31 August 2020

7 references

13 March 2019

14 March 2019

24 March 2019

20 November 2019

29 May 2020

31 August 2020

4 February 2021

96

0 references

e6583

0 references

15

0 references

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

6 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

14 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

20 November 2019

Europe PubMed Central

31 August 2020

Europe PubMed Central

4 February 2021

on focus list of Wikimedia project

0 references

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

21 May 2017

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

21 May 2017

Obesity, Inflammation, and Insulin Resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

21 May 2017

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

21 May 2017

Transforming growth factor beta in tissue fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

21 May 2017

Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: A systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Global estimates of diabetes prevalence for 2013 and projections for 2035.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Adiponectin and IL-6: Mediators of inflammation in progression of healthy to type 2 diabetes in Indian population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

The role of inflammatory cytokines in diabetes and its complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

The role of inflammatory cytokines in diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Diabetic nephropathy and retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

3 June 2018

The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

26 November 2018

Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

26 November 2018

Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403085

26 November 2018

Heterogeneity testing in meta-analysis of genome searches

1 reference

https://pubmed.ncbi.nlm.nih.gov/28403088

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28403088

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Infect of pingshen decoction on serum HGF, Cys C and TGF-beta1 diabetic nephropathy in early stage]

1 reference

https://pubmed.ncbi.nlm.nih.gov/28403088

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/28403088

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of transforming growth factor-β1 in diabetic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/28403088

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/28403088

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased renal production of transforming growth factor-beta1 in patients with type II diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28403088

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/MD.0000000000006583

0 references

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29994602&oldid=1460051238"